The hormone ghrelin has been shown to alleviate anorexia and vomiting in animal models and reduce cachexia and nausea in cancer patients, activities thought to be related to its ability to promote appetite (and perhaps “hedonistic eating” via a constitutively-active receptor; see Sanger and Furness, 2016). This evidence concerns the gene GHRL and cancer.